TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32707289

Group type: EXPERIMENTAL
Intervention: Abdominal hypopressive technique (AHT) programme for 2 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Rest for 2 months
Number of subjects: 42
Study: 35184691

Group type: EXPERIMENTAL
Intervention: Single dose intravenous cefuroxime after cord clamping (n=19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single dose intravenous cefuroxime 30 minutes before skin incision (n=21)
Number of subjects: 40
Study: 34516712

Group type: EXPERIMENTAL
Intervention: Robot-assisted MIS-TLIF
Number of subjects: 48

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 48
Study: 32524118

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaling for 60 seconds on crowns cemented with resin modified glass cement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaling for 60 seconds on crowns cemented with resin cement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Comparison of micro-leakage between zirconia crown and glass-ceramic crown with or without ultrasonic scaling
Number of subjects: 48
Study: 35481572

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (25 mg twice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 34721414

Group type: EXPERIMENTAL
Intervention: Dexamethasone stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline CD4+ Ki-67 and FKBP51 expression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of FKBP51 expression in CD8+ T cells and CD19+ B cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polarization profiles for Th1, Th2, Th9, or Th17 percentage
Number of subjects: 0
Study: 35811518

Group type: EXPERIMENTAL
Intervention: Personalized, precision medicine protocol for nine months
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MRI volumetrics
Number of subjects: 25
Study: 33440446

Group type: EXPERIMENTAL
Intervention: VAR group (different exercises)
Number of subjects: 22

Group type: COMPARATOR
Intervention: N-VAR group (same exercises)
Number of subjects: 22
Study: 32381031

Group type: EXPERIMENTAL
Intervention: Implementation of an algorithm for early detection and minimally invasive management of pancreatic fistula
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Current practice
Number of subjects: 1600
Study: 35311446

Group type: EXPERIMENTAL
Intervention: Multi-fiber bread (150 g daily, enriched with a 7-dietary fiber mixture providing 16.05 g of fibers)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Multi-fiber bread
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control bread (standard bread, 150 g daily)
Number of subjects: 39
Study: 32554133

Group type: EXPERIMENTAL
Intervention: Web-based cognitive training video game (Aquasnap) for 6 months, at least 3 times a week for a minimum of 60 minutes per week, in addition to standard care
Number of subjects: 46

Group type: COMPARATOR
Intervention: Delayed intervention group received standard care for 3 months followed by 3 months of MyCQ training
Number of subjects: 46
Study: 34391239

Group type: EXPERIMENTAL
Intervention: Miofascial Release (MFR) applied for 3min
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Miofascial Release (MFR) applied for 5min
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo group (non-therapeutic gel with light touch for 3min)
Number of subjects: 51
Study: 32194094

Group type: EXPERIMENTAL
Intervention: Raloxifene and Vitamin D in nanostructure lipid carriers (NLCs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial product
Number of subjects: 0
Study: 34743663

Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: bimanual training (BIM)
Number of subjects: 30
Study: 34446763

Group type: EXPERIMENTAL
Intervention: High cognitive functioning group (14 patients, 15%)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Medium cognitive functioning group (58 patients, 62%)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Low cognitive functioning group (22 patients, 23%)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cognitively impaired patients at baseline (52 patients, 55%)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Patients with the poorest cognitive function
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Impact on activities of daily living
Number of subjects: 94
Study: 32568452

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 80
Study: 35614486

Group type: EXPERIMENTAL
Intervention: MR-guided SBRT starting at 10 × 5.5 Gy, escalating up to 10 × 6.5 Gy
Number of subjects: 38
Study: 34421016

Group type: EXPERIMENTAL
Intervention: text4FATHER intervention
Number of subjects: 0
Study: 34879902

Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: OSA+insomnia
Number of subjects: 224

Group type: COMPARATOR
Intervention: OSA
Number of subjects: 224
Study: 35614564

Group type: EXPERIMENTAL
Intervention: multimedia-based assent document
Number of subjects: 116

Group type: COMPARATOR
Intervention: paper-based assent document
Number of subjects: 116
Study: 33532013

Group type: EXPERIMENTAL
Intervention: 10 mg amitriptyline at bedtime
Number of subjects: 80

Group type: COMPARATOR
Intervention: 5 mg amitriptyline at bedtime
Number of subjects: 80
Study: 32315958

Group type: EXPERIMENTAL
Intervention: 600 mg/d of sodium butyrate (NaBut)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10 g/d of high‐performance (HP) inulin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 600 mg/d of sodium butyrate + 10 g/d of HP inulin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34215548

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33772794

Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35546101

Group type: EXPERIMENTAL
Intervention: Intact fish skin grafts (FSGs)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 51
Study: 33262022

Group type: EXPERIMENTAL
Intervention: Red cell transfusion
Number of subjects: 270

Group type: COMPARATOR
Intervention: Not transfused
Number of subjects: 270
Study: 33722585

Group type: EXPERIMENTAL
Intervention: Quadrivalent high-dose influenza vaccine (QIV-HD)
Number of subjects: 120000

Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine (QIV-SD)
Number of subjects: 120000
Study: 32941349

Group type: EXPERIMENTAL
Intervention: TEG/ROTEM-guided blood transfusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional coagulation parameters
Number of subjects: 0
Study: 34224987

Group type: EXPERIMENTAL
Intervention: Insulin administered intravenously to keep arterial blood glucose between 6 and 8 mmol/l during surgery
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group received insulin if blood glucose >11.5 mmol/l
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Insulin control
Number of subjects: 18
Study: 32644915

Group type: EXPERIMENTAL
Intervention: Days with rAAA
Number of subjects: 717

Group type: COMPARATOR
Intervention: Control days
Number of subjects: 717
Study: 35422497

Group type: EXPERIMENTAL
Intervention: Water chlorination
Number of subjects: 130
Study: 36541222

Group type: COMPARATOR
Intervention: Arm A - Lip and soft palate closure at 3-4 months followed by hard palate closure at 12 months
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Arm B - Lip and soft palate closure at 3-4 months, hard palate closure at 36 months
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Arm C - Lip closure at 3-4 months, hard and soft palate closure at 12 months
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Arm D - Lip closure at 3-4 months, single-layer closure of hard palate using a vomer flap, soft palate closure at 12 months
Number of subjects: 431
Study: 33895306

Group type: EXPERIMENTAL
Intervention: All-suture suture anchor (ASSA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional interference screw (CIS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison between ASSA and CIS
Number of subjects: 18
Study: 32410684

Group type: EXPERIMENTAL
Intervention: Sex education program (two 90-min sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 36181316

Group type: EXPERIMENTAL
Intervention: PegIFN‐α monotherapy (180 μg/week)
Number of subjects: 260
Study: 33633016

Group type: EXPERIMENTAL
Intervention: 1% Phentolamine mesylate ophthalmic solution (PMOS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 1% Phentolamine mesylate ophthalmic solution (PMOS) in the tropicamide subgroup
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 36141895

Group type: EXPERIMENTAL
Intervention: Climbing exercise (n = 27)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nordic walking exercise (n = 23)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition (social contact, n = 23)
Number of subjects: 60
Study: 33202447

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1155

Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 1155
Study: 36090843

Group type: EXPERIMENTAL
Intervention: Co-development of activities to tackle substance use
Number of subjects: 880

Group type: COMPARATOR
Intervention: Control group participation in activities
Number of subjects: 880
Study: 34726625

Group type: EXPERIMENTAL
Intervention: Immediate neoadjuvant instillation of chemotherapy (INAIC) with mitomycin C before TURBT (Group A)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group with TURBT only (Group B)
Number of subjects: 124
Study: 32366224

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream (2 g applied to the tracheal tube cuff)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Vaseline 2 g applied to the tracheal tube cuff)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Vaseline)
Number of subjects: 0
Study: 34596367

Group type: EXPERIMENTAL
Intervention: Anlotinib 12 mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32354228

Group type: EXPERIMENTAL
Intervention: 6-month DAPT
Number of subjects: 2712

Group type: EXPERIMENTAL
Intervention: PRECISE-DAPT score
Number of subjects: 2712
Study: 33461937

Group type: EXPERIMENTAL
Intervention: Nomogram using a four-marker signature (CA19-9, CA125, CA50, CA242)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Kaplan-Meier survival analysis
Number of subjects: 558
Study: 33190804

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36253987

Group type: EXPERIMENTAL
Intervention: Wuwei Fuzheng Yijing Decoction (WWFZYJ)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Coenzyme Q10 tablets combined with vitamin E soft capsules
Number of subjects: 66
Study: 34380375

Group type: EXPERIMENTAL
Intervention: Underwater posterior nasal neurectomy with submucous inferior turbinectomy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Resection of peripheral branches of posterior nasal nerve with turbinoplasty (Control group)
Number of subjects: 43
Study: 32795875

Group type: EXPERIMENTAL
Intervention: 70-gene signature (MammaPrint®) guided treatment strategy
Number of subjects: 1497

Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 1497
Study: 35756497

Group type: EXPERIMENTAL
Intervention: Standardized nutritional intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional nursing
Number of subjects: 100
Study: 34709369

Group type: EXPERIMENTAL
Intervention: Low-dose CT of the chest
Number of subjects: 171

Group type: COMPARATOR
Intervention: CXR
Number of subjects: 171
Study: 35552709

Group type: EXPERIMENTAL
Intervention: Vincristine and dexamethasone every 4 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Vincristine and dexamethasone every 12 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Proxy-reported outcomes
Number of subjects: 150
Study: 32663386

Group type: EXPERIMENTAL
Intervention: 830 mg CF (CF830)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 1,245 mg CF (CF1245)
Number of subjects: 23

Group type: COMPARATOR
Intervention: 0 mg CF (Control)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of Control and CF1245
Number of subjects: 23
Study: 34664357

Group type: EXPERIMENTAL
Intervention: FCL plus topical tazarotene 0.1% gel
Number of subjects: 27

Group type: COMPARATOR
Intervention: Topical tazarotene 0.1% gel only
Number of subjects: 27
Study: 34776135

Group type: EXPERIMENTAL
Intervention: VMO facilitatory kinesio taping
Number of subjects: 32

Group type: COMPARATOR
Intervention: VL inhibitory kinesio taping
Number of subjects: 32
Study: 32580535

Group type: EXPERIMENTAL
Intervention: School closing (Scenario I)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: School opening after April 6 (Scenario II)
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: School opening after April 6 and mean period from symptom onset to hospitalization increasing to 4.3 days (Scenario III)
Number of subjects: 9000
Study: 36177965

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery using Preceyes Surgical System (PSS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Manual surgery
Number of subjects: 15
Study: 33980315

Group type: EXPERIMENTAL
Intervention: Housing + opioid and related risk prevention services
Number of subjects: 240

Group type: COMPARATOR
Intervention: Opioid and related risk prevention services alone
Number of subjects: 240
Study: 32486583

Group type: EXPERIMENTAL
Intervention: Loading dose of levosimendan (0.1 μg·kg(‐1)·min(‐1) for 24 h after loading with 6 μg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Maintenance dose of levosimendan (same schedule without loading dose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32
Study: 35288394

Group type: EXPERIMENTAL
Intervention: Anaemia (severe, moderate, mild)
Number of subjects: 2023

Group type: EXPERIMENTAL
Intervention: Anaemia (severe to moderate)
Number of subjects: 2023

Group type: EXPERIMENTAL
Intervention: Anaemia
Number of subjects: 2023
Study: 32876732

Group type: EXPERIMENTAL
Intervention: Sublingual atropine (600-μg dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 35869311

Group type: EXPERIMENTAL
Intervention: Concentrated beetroot juice (BJ) 24 ml daily for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Concentrated beetroot juice (BJ)
Number of subjects: 46
Study: 34463946

Group type: EXPERIMENTAL
Intervention: LOFF-LESS (gasless laparoscopic operation field formation device)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LESS (conventional CO2 pneumoperitoneum)
Number of subjects: 100
Study: 36438250

Group type: EXPERIMENTAL
Intervention: Combined Training (CT) program (16 weeks of resistance and aerobic exercise)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (non-exercise)
Number of subjects: 31
Study: 33155357

Group type: EXPERIMENTAL
Intervention: Postoperative isometric exercises (EG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 27
Study: 35871071

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) for 4 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) for 12 weeks (STOP arm)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo for 12 weeks (STOP arm)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combined HCQ treatment periods
Number of subjects: 35

Group type: COMPARATOR
Intervention: Combined placebo treatment periods
Number of subjects: 35
Study: 34218941

Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2-Dimensional Full Field Digital Mammography (FFDM)
Number of subjects: 0
Study: 33218560

Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo diacutaneous fibrolysis
Number of subjects: 35
Study: 36239406

Group type: EXPERIMENTAL
Intervention: Oxytocin 2.5 IU
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carbetocin 100 μg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both Oxytocin and Carbetocin
Number of subjects: 40
Study: 34288591

Group type: EXPERIMENTAL
Intervention: Home infusions of natalizumab (n=18)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual care (hospital out‐patients’ clinic) (n=19)
Number of subjects: 37
Study: 32781869

Group type: EXPERIMENTAL
Intervention: sl‐wIRAR treatment (2 treatments for 30 min per day for 6 days)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: sl‐wIRAR treatment
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: NSAID therapy reduction
Number of subjects: 71
Study: 35949389

Group type: EXPERIMENTAL
Intervention: Pain Relief Kit
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 32591370

Group type: EXPERIMENTAL
Intervention: Durvalumab (MEDI-4736)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Physician's choice chemotherapy
Number of subjects: 46
Study: 34579142

Group type: EXPERIMENTAL
Intervention: Lifestyle, Exercise, and Nutrition (LEAN) Study
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 35064733

Group type: EXPERIMENTAL
Intervention: Maximal behavioural intervention (intensive contact schedule, education, motivational interviewing, value-based activity planning during 12 weeks)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Minimal behavioural intervention (short contact only)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Maximal behavioural intervention
Number of subjects: 179

Group type: COMPARATOR
Intervention: Minimal behavioural intervention
Number of subjects: 179
Study: 33021110

Group type: EXPERIMENTAL
Intervention: Zonisamide as an adjunctive treatment to levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levodopa monotherapy
Number of subjects: 0
Study: 37115133

Group type: COMPARATOR
Intervention: Polypharmacy (≥5 medications excluding HFrEF GDMT) at baseline
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: No polypharmacy (<5 medications) at baseline
Number of subjects: 891

Group type: COMPARATOR
Intervention: Polypharmacy at baseline
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: No polypharmacy at baseline
Number of subjects: 891
Study: 32914554

Group type: COMPARATOR
Intervention: Cornea Max (serum‐based)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cornea Syn (synthetic)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Human corneal endothelial cell (HCEnC) culture
Number of subjects: 64
Study: 32754930

Group type: EXPERIMENTAL
Intervention: Essentialist thinking toward biosocial risk factors for criminality
Number of subjects: 897

Group type: EXPERIMENTAL
Intervention: Essentialist thinking toward types of offending
Number of subjects: 897

Group type: EXPERIMENTAL
Intervention: Essentialist thinking toward discreteness and informativeness
Number of subjects: 897
Study: 33448466

Group type: EXPERIMENTAL
Intervention: Ketone-ester (395 mg/kg) + carbohydrate drink (30 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Carbohydrate drink (66 g)
Number of subjects: 6
Study: 33080693

Group type: EXPERIMENTAL
Intervention: Acupuncture with deqi
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Acupuncture without deqi
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waiting-list group
Number of subjects: 108
Study: 34251539

Group type: EXPERIMENTAL
Intervention: Single leg heating intervention (EXP) - immersion in 42.5℃ water for five 35-min sessions/week for 8 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control leg (CON)
Number of subjects: 13
Study: 34791237

Group type: EXPERIMENTAL
Intervention: Wrist-worn ActiGraph accelerometer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hip-worn ActiGraph accelerometer
Number of subjects: 0
Study: 32304003

Group type: EXPERIMENTAL
Intervention: Excimer laser coronary atherectomy (ELCA) prior to paclitaxel-coated balloon angioplasty
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no ELCA)
Number of subjects: 118
Study: 33238818

Group type: EXPERIMENTAL
Intervention: Data-driven coaching that integrated observational assessment and performance feedback
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Data-driven coaching for SE teachers
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control condition (no coaching)
Number of subjects: 106
Study: 36088609

Group type: EXPERIMENTAL
Intervention: Luminor® 35 drug‐coated balloon (DCB) angioplasty
Number of subjects: 171

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 171
Study: 34779646

Group type: EXPERIMENTAL
Intervention: Olaparib with or without bevacizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-fluorouracil plus bevacizumab
Number of subjects: 0
Study: 35662491

Group type: EXPERIMENTAL
Intervention: Active Early Learning intervention
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 314
Study: 33430216

Group type: EXPERIMENTAL
Intervention: Strength group (S)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Endurance group (E)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Combined strength and endurance group (SE)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 239
Study: 32174446

Group type: EXPERIMENTAL
Intervention: Flexible pacing during assembly of customised products
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restrictive pacing during assembly of customised products
Number of subjects: 0
Study: 35270595

Group type: EXPERIMENTAL
Intervention: Tobacco smoking
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nicotine vaping
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nicotine-free vaping
Number of subjects: 15
Study: 32584155

Group type: EXPERIMENTAL
Intervention: AKL-T03 (videogame-like digital treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AKL-T09 (control word game)
Number of subjects: 0